Cargando…

Serum Metabolic Profile in Multiple Sclerosis Patients

Multiple sclerosis (MS) is a progressive demyelinating process considered as an autoimmune disease, although the causes of this pathology have not been yet fully established. Similarly to other neurodegenerations, MS is characterized by a series of biochemical changes affecting to different extent n...

Descripción completa

Detalles Bibliográficos
Autores principales: Tavazzi, Barbara, Batocchi, Anna Paola, Amorini, Angela Maria, Nociti, Viviana, D'Urso, Serafina, Longo, Salvatore, Gullotta, Stefano, Picardi, Marika, Lazzarino, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196932/
https://www.ncbi.nlm.nih.gov/pubmed/22096628
http://dx.doi.org/10.1155/2011/167156
_version_ 1782214255428239360
author Tavazzi, Barbara
Batocchi, Anna Paola
Amorini, Angela Maria
Nociti, Viviana
D'Urso, Serafina
Longo, Salvatore
Gullotta, Stefano
Picardi, Marika
Lazzarino, Giuseppe
author_facet Tavazzi, Barbara
Batocchi, Anna Paola
Amorini, Angela Maria
Nociti, Viviana
D'Urso, Serafina
Longo, Salvatore
Gullotta, Stefano
Picardi, Marika
Lazzarino, Giuseppe
author_sort Tavazzi, Barbara
collection PubMed
description Multiple sclerosis (MS) is a progressive demyelinating process considered as an autoimmune disease, although the causes of this pathology have not been yet fully established. Similarly to other neurodegenerations, MS is characterized by a series of biochemical changes affecting to different extent neuronal functions; great attention has been given to oxidative/nitrosative stress and to alterations in mitochondrial functions. According to previous data, MS patients show significant changes in the circulating concentrations of different metabolites, although it is still unclear whether uric acid undergoes to decrease, increase, or no change under this pathological condition. In this study, we report the serum metabolic profile in terms of purines, pyrimidines, creatinine, malondialdehyde, ascorbic acid, nitrite, and nitrate in a group of 170 MS patients. The results show increase in circulating uric acid and other oxypurines (hypoxanthine and xanthine), as well as in uridine and β-pseudouridine. The concomitant increase in circulating creatinine, malondialdehyde, nitrite, and nitrate, and decrease in ascorbic acid, demonstrates that MS induces alteration in energy metabolism and in oxidants/antioxidants balance that can be monitored in serum of MS patients.
format Online
Article
Text
id pubmed-3196932
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-31969322011-11-17 Serum Metabolic Profile in Multiple Sclerosis Patients Tavazzi, Barbara Batocchi, Anna Paola Amorini, Angela Maria Nociti, Viviana D'Urso, Serafina Longo, Salvatore Gullotta, Stefano Picardi, Marika Lazzarino, Giuseppe Mult Scler Int Research Article Multiple sclerosis (MS) is a progressive demyelinating process considered as an autoimmune disease, although the causes of this pathology have not been yet fully established. Similarly to other neurodegenerations, MS is characterized by a series of biochemical changes affecting to different extent neuronal functions; great attention has been given to oxidative/nitrosative stress and to alterations in mitochondrial functions. According to previous data, MS patients show significant changes in the circulating concentrations of different metabolites, although it is still unclear whether uric acid undergoes to decrease, increase, or no change under this pathological condition. In this study, we report the serum metabolic profile in terms of purines, pyrimidines, creatinine, malondialdehyde, ascorbic acid, nitrite, and nitrate in a group of 170 MS patients. The results show increase in circulating uric acid and other oxypurines (hypoxanthine and xanthine), as well as in uridine and β-pseudouridine. The concomitant increase in circulating creatinine, malondialdehyde, nitrite, and nitrate, and decrease in ascorbic acid, demonstrates that MS induces alteration in energy metabolism and in oxidants/antioxidants balance that can be monitored in serum of MS patients. Hindawi Publishing Corporation 2011 2011-06-28 /pmc/articles/PMC3196932/ /pubmed/22096628 http://dx.doi.org/10.1155/2011/167156 Text en Copyright © 2011 Barbara Tavazzi et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Tavazzi, Barbara
Batocchi, Anna Paola
Amorini, Angela Maria
Nociti, Viviana
D'Urso, Serafina
Longo, Salvatore
Gullotta, Stefano
Picardi, Marika
Lazzarino, Giuseppe
Serum Metabolic Profile in Multiple Sclerosis Patients
title Serum Metabolic Profile in Multiple Sclerosis Patients
title_full Serum Metabolic Profile in Multiple Sclerosis Patients
title_fullStr Serum Metabolic Profile in Multiple Sclerosis Patients
title_full_unstemmed Serum Metabolic Profile in Multiple Sclerosis Patients
title_short Serum Metabolic Profile in Multiple Sclerosis Patients
title_sort serum metabolic profile in multiple sclerosis patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196932/
https://www.ncbi.nlm.nih.gov/pubmed/22096628
http://dx.doi.org/10.1155/2011/167156
work_keys_str_mv AT tavazzibarbara serummetabolicprofileinmultiplesclerosispatients
AT batocchiannapaola serummetabolicprofileinmultiplesclerosispatients
AT amoriniangelamaria serummetabolicprofileinmultiplesclerosispatients
AT nocitiviviana serummetabolicprofileinmultiplesclerosispatients
AT dursoserafina serummetabolicprofileinmultiplesclerosispatients
AT longosalvatore serummetabolicprofileinmultiplesclerosispatients
AT gullottastefano serummetabolicprofileinmultiplesclerosispatients
AT picardimarika serummetabolicprofileinmultiplesclerosispatients
AT lazzarinogiuseppe serummetabolicprofileinmultiplesclerosispatients